Lodepine

Quick links to important sections

Lodepine

Selected form

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lodepine

Quick Facts

Property Description
Active Ingredient Amlodipine (as Besylate salt)
Form Oral tablet (most common)
Pharmacological Class Calcium Channel Blocker (Dihydropyridine CCB)
Route of Administration Oral
Origin Synthetic compound

Lodepine is a prescription-only medication primarily used for cardiovascular management. Its identity is defined by the active pharmaceutical ingredient (API), Amlodipine, and its classification as a Calcium Channel Blocker (CCB). The drug is consistently formulated as an oral tablet for once-daily dosing, a schedule facilitated by its prolonged duration of action.

Defining Lodepine: A Cardiovascular Calcium Channel Blocker

Lodepine belongs to the highly vascular-selective Dihydropyridine subclass of Calcium Channel Blockers. This classification signifies its mechanism: it regulates the movement of calcium ions into specific smooth muscle cells. The active component, Amlodipine, acts directly to relax blood vessels, which reduces arterial blood pressure.

Differentiation: Focus on Sustained Action

A key differentiating factor of Amlodipine is its long elimination half-life, which can range from 30 to 50 hours. Due to this sustained action, antihypertensive effectiveness is maintained for at least 24 hours with chronic once-daily oral administration, contributing to its widespread use.

Composition and Origin: The Synthetic Amlodipine Besylate

Lodepine is a single-active-ingredient product derived from synthetic chemistry. The formulation utilizes Amlodipine Besylate, a stable salt structure. This Besylate salt is chosen to ensure the drug’s stability and consistent absorption from the oral tablet dosage form. The medication's function is tied to its structure as a Dihydropyridine, which promotes vasodilation, the widening of the arteries. This mechanism reduces the peripheral vascular resistance that the heart must overcome.

What side effects are possible with Lodepine?

Possible Side Effects and Safety Information

This section outlines the possible adverse reactions and safety considerations for Lodepine (Amlodipine Besylate), strictly based on official government regulatory documentation.

Frequency-Classified Adverse Reactions

Adverse reactions are officially classified by the frequency of their occurrence, derived from clinical trials and post-marketing surveillance reports. The most frequently reported reactions include peripheral edema (swelling), headache, and fatigue. These are typically categorized as Common (affecting 1 in 100 to 1 in 10 people).

Other adverse reactions are categorized as Uncommon (e.g., dizziness, abdominal pain, nausea), Rare, or Very Rare (affecting less than 1 in 10,000 people). These reactions affect various body systems, including Nervous System, Gastrointestinal, Skin, and Cardiovascular Systems.

Frequency Classification Examples of Affected Systems
Very Common (≥ 1/10) None officially categorized at this level.
Common (≥ 1/100 to < 1/10) Nervous System, General Disorders, Vascular Disorders.
Uncommon (≥ 1/1,000 to < 1/100) Gastrointestinal, Skin and Subcutaneous Tissue, Musculoskeletal.
Very Rare (< 1/10,000) Hematologic, Hepato-biliary, Cardiac.

Serious and Clinically Significant Safety Concerns

Though rare, regulatory documents highlight potentially serious adverse reactions. These include severe liver-related events such as hepatitis and jaundice, severe skin reactions like Toxic Epidermal Necrolysis (TEN) and Erythema Multiforme, and certain cardiovascular events like myocardial infarction and arrhythmia (ventricular tachycardia, atrial fibrillation).

Safety Restrictions and Population Considerations

Lodepine is contraindicated in patients with cardiogenic shock, severe low blood pressure (hypotension), and hypersensitivity to dihydropyridines. Caution and potential dose adjustment are officially recommended for use in the elderly and in patients with impaired hepatic function, as drug clearance may be reduced in these groups. Safety in pregnancy and lactation is not fully established.

Overdose and Emergency Response

An overdose of Lodepine (Amlodipine Besylate) is officially described in regulatory documents as presenting primarily with profound cardiovascular effects. The core manifestation is a high degree of peripheral vasodilatation, leading to significant and prolonged systemic hypotension (very low blood pressure). This can result in reflex tachycardia (rapid heart rate) and associated symptoms such as fainting.

The most severe documented outcomes include the potential progression of the severe hypotension to shock and, in rare instances, fatal outcomes.

Immediate medical attention is required for all suspected overdoses. Regulatory guidance mandates that individuals seek immediate medical attention and contact the Poison Help Line. Furthermore, emergency services (e.g., 911) must be called immediately if the victim has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.

Management procedures are symptomatic and supportive. Official prescribing information states that no specific antidote is known to reverse amlodipine's effects. Because of the drug's prolonged half-life, active cardiac and respiratory monitoring is required, often necessitating extended clinical observation. Supportive procedures officially documented include providing cardiovascular support, administering judicious intravenous fluids, and using vasopressors if hypotension is unresponsive to conservative measures. Hemodialysis is officially documented as being unlikely to be of benefit due to the drug’s high protein binding.

Therapeutic Uses of Lodepine

What Lodepine (Amlodipine Besylate) Treats: Main Uses and Benefits

Lodepine (Amlodipine Besylate) is applied across domains where additional symptomatic support is needed to manage key cardiovascular conditions. It is commonly used for easing hypertension (high blood pressure), specific types of angina (chest pain), and the symptomatic burden associated with Coronary Artery Disease (CAD).

This medicine is relevant for the management of these conditions, helping to address symptom clusters that may appear suddenly or fluctuate. It is used in clinical settings that involve acute or unstable symptom patterns, contributing to improved comfort during symptomatic periods, and provides supportive relief when symptoms interfere with routine activities.

“Lodepine assists with maintaining functional stability and helps patients cope more steadily with difficult episodes.”


Quick Fact: Relief for Angina

Quick Fact: Relief for Chest Pain (Angina). Lodepine is relevant for easing certain distressing symptoms.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Lodepine (Amlodipine Besylate) is a calcium channel blocker used to treat high blood pressure (hypertension) and certain types of angina (chest pain) and coronary artery disease. It is generally suitable for most adults and children aged 6 and older for hypertension.

However, Amlodipine is contraindicated (should not be used) in patients with a known hypersensitivity or allergic reaction to amlodipine or any other dihydropyridine calcium channel blockers.


Caution is advised

Careful medical assessment and potential dose adjustment are necessary for certain patient groups or individuals with specific medical conditions. It is crucial to inform a healthcare provider if you have or have had:

  • Severe Aortic Stenosis (severe narrowing of the aortic valve).
  • Severe Liver Impairment/Failure, as the drug is extensively metabolized by the liver, requiring slower titration of the dose.
  • Heart Failure, especially non-ischemic heart failure.
  • Severe Obstructive Coronary Artery Disease, as there is a risk of worsening angina or acute myocardial infarction, particularly upon starting or increasing the dose.
  • Pregnancy or Breastfeeding: Use during pregnancy is generally advised only if the potential benefit justifies the risk. Amlodipine is present in breast milk, and a doctor should be consulted.

Patients who are elderly or frail may also require a lower starting dose due to potentially decreased hepatic, renal, or cardiac function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Lodepine (Amlodipine Besylate) documents several types of interactions that may impact drug exposure or clinical effect.

Drug-Drug and Pharmacokinetic Interactions

Amlodipine is a substrate of the CYP3A4 metabolic pathway. Co-administration with strong or moderate CYP3A4 inhibitors, such as Diltiazem or Verapamil, is officially associated with increased plasma exposure of Amlodipine, which may increase the risk of hypotensive effects. A formal contraindication exists for combining Amlodipine with Dantrolene (intravenous). Co-administration with Simvastatin carries a mandatory dose restriction: the Simvastatin dose must not exceed 20 mg daily due to a significant regulatory-documented increase in Simvastatin exposure. Transporter-mediated interactions also occur, causing increased exposure of the immunosuppressants Cyclosporin and Tacrolimus when co-administered. The effects of these pharmacokinetic variations may be more pronounced in elderly patients and those with hepatic impairment, where Amlodipine clearance is officially noted as decreased.

Pharmacodynamic and Substance Interactions

Co-administration with other antihypertensive agents results in an additive blood pressure lowering effect. Similarly, alcohol (ethanol) may have additive effects in reducing blood pressure. The co-ingestion of Grapefruit or Grapefruit juice is officially not recommended as it may increase the bioavailability of Amlodipine in certain individuals.

Mechanism of Action

Molecular Mechanism: Selective L-Type Calcium Channel Blockade

The mechanism of Amlodipine is rooted in its selective action as an antagonist of voltage-dependent L-type calcium channels (Cav1.2), primarily on vascular smooth muscle cells. The drug binds to and inhibits the passage of extracellular calcium ions (Ca^2+) into the cell, which is the essential molecular trigger for muscle contraction. This action directly disrupts the Calcium-Calmodulin cascade, resulting in the modulation of arterial muscle tone.


Causal Cascade: Reduction of Peripheral Vascular Resistance

The resulting inhibition of smooth muscle contraction leads to sustained arterial dilation (vasodilation), initiating a systemic physiological cascade. This process reduces the overall Total Peripheral Resistance ( TPR) in the circulatory system. This mechanism reduces the mechanical load ( afterload) imposed on the heart, leading to a predictable physiological adjustment in arterial pressure. The drug's inherent vascular selectivity results in a minimal impact on cardiac contractile force.

Dosage and Administration Information

How to Use Lodepine (Amlodipine Besylate)

Amlodipine besylate is administered exclusively via the oral route, typically available as tablets, with standardized oral solution and suspension forms also utilized. The standardized regimen specifies once-daily administration, a frequency facilitated by the drug’s prolonged duration of action, which maintains an antihypertensive effect for at least 24 hours.


Official Dosing and Administration

The medicine may be taken with or without food for convenience, but it is generally recommended to maintain a consistent time of day for dosing.

Usage Parameter Official Adult Instructions (General) Population-Specific Instructions
Starting Dose 5 mg once daily 2.5 mg once daily for small, frail, or elderly patients and those with hepatic impairment.
Maintenance Range 5 mg to 10 mg once daily Pediatric (Ages 6–17) dose range is 2.5 mg to 5 mg once daily.
Maximum Dose 10 mg once daily 5 mg once daily maximum for the pediatric population.

Procedural and Timing Instructions

Dosage adjustments are determined by the treating clinician and should generally proceed slowly over a period of 7 to 14 days to fully assess the sustained response before any change is made to a higher dose. For liquid forms, the product must be shaken well prior to administration and measured with a calibrated device. If a dose is missed, it should be taken when remembered, unless it is close to the time for the next scheduled dose; in this instance, the missed dose must be skipped, and a double dose should never be taken. The medication is generally used as part of a long-term treatment plan.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Lodepine (Amlodipine Besylate)

Evidence for Use in Hypertension (High Blood Pressure)

Lodepine was studied for the management of high blood pressure in numerous clinical trials, including large, Randomized Controlled Trials (RCTs) designed for long-term follow-up. This research primarily included adults diagnosed with mild to severe essential hypertension. Researchers focused on two main axes: evaluating changes in Systolic and Diastolic Blood Pressure (BP) measurements and tracking the occurrence of Major Cardiovascular Events over the study periods.

The short-term trials reported distinct measurements that reflected changes in blood pressure levels when compared to placebo. Long-term research examined patterns in the incidence of major events like non-fatal heart attack or stroke in Amlodipine-based regimens compared to other treatments studied in the same trials. Findings describe the patterns of cardiovascular event rates observed in the studies when Amlodipine-based therapy was compared to certain other regimens.

One of the limitations noted is that data for certain complex subgroups (such as patients with multiple pre-existing conditions) remain insufficient or are still emerging. Comparative evidence is lacking for Amlodipine against every single alternative treatment option.


Evidence for Use in Angina and Coronary Artery Disease (CAD)

For conditions characterized by episodic or acute changes in chest pain (angina), Lodepine was evaluated in specific clinical trials involving adults with chronic stable angina or vasospastic angina. The research explored short-term symptom changes by evaluating the Frequency and Duration of Angina Episodes reported per week. Studies also monitored outcomes related to daily functioning or activity level, such as Exercise Tolerance during standardized testing.

Longer-term observational studies were conducted in patient cohorts with documented Coronary Artery Disease (CAD), tracking outcomes related to hospitalization for angina and the need for coronary revascularization procedures. Findings describe patterns observed in the studies where Amlodipine use was associated with differences in the rates of hospitalization for angina and revascularization procedures when compared to a placebo in patients with recently documented CAD.

What remains uncertain is the effect of Amlodipine on the physical progression of coronary vessel narrowing (atherosclerosis) itself; one research protocol reported that measurements in this specific area did not show a distinct pattern between the Amlodipine group and the placebo group, even though clinical events were tracked.


Evidence in Special Populations and Research Gaps

Amlodipine was studied for use in patient groups whose characteristics differ from the general adult population, including older adults (geriatric patients) where the evidence base includes the observation of blood pressure and cardiovascular event patterns consistent with the overall adult population.

Research was conducted in children and adolescents (typically ages 6 to 17 years) with hypertension, focusing on blood pressure measurements. Studies report patterns of changes in blood pressure in this population, with stability of the measured outcomes observed over periods of up to two years. However, data for certain groups remain insufficient for children younger than 6 years of age, and certainty remains low in this population. Evidence quality varies across studies when comparing Amlodipine to a wide array of other anti-hypertensive drugs across various secondary outcomes.

Frequently Asked Questions (FAQ)

Common questions about Lodepine (Amlodipine Besylate) (FAQ)

Q: Why does Lodepine cause ankle or leg swelling (peripheral edema)?

Official product information notes that peripheral swelling (edema) is a common side effect associated with this medication. This is due to the drug's action as a calcium channel blocker, which causes blood vessels to relax (vasodilation). This widening of blood vessels can lead to a fluid imbalance, often resulting in fluid pooling in the lower extremities.

Q: How common are muscle cramps associated with Lodepine?

Muscle cramps, stiffness, or tremors are listed in regulatory documents as an uncommon side effect, meaning it may affect up to 1 in 100 people. If a patient experiences persistent muscle cramps, they should consult their prescriber regarding the symptoms.

Q: Why is Lodepine sometimes associated with skin flushing?

Flushing, defined as a warm or hot feeling accompanied by redness, is a reported side effect of Lodepine. This effect is directly related to the drug's mechanism of action, as its vasodilatory effects cause peripheral blood vessels near the skin's surface to widen.

Q: How long does it take for Lodepine to start lowering high blood pressure?

Regulatory information indicates that the maximum blood pressure-lowering effect is delayed. Clinical guidelines suggest that dosage adjustment, if necessary, is typically made after a period of 7 to 14 days to allow the full sustained response to be measured.

Q: Can people with liver or kidney impairment use Lodepine?

For mild to moderate kidney impairment, no specific dosage adjustment is typically required based on official information. However, since the medicine is metabolized by the liver, the official prescribing information notes that patients with severe liver impairment may require a lower starting dose.

Q: Does Lodepine affect heart rate or cause palpitations?

Palpitations, the sensation of a fast or irregular heartbeat, are listed as a common side effect in the official safety profile. A decrease in heart rate is also noted as an uncommon side effect.

Q: Do the side effects of Lodepine usually go away after the first few weeks?

Common side effects, such as headaches and flushing, are often reported to be mild and temporary. These symptoms may lessen or resolve after the first few days or weeks of treatment as the body adjusts to the medication.

Q: Can Lodepine cause hair thinning or loss?

Hair loss (alopecia) is noted in the official regulatory documents as an adverse reaction. This effect is typically classified as uncommon or very rare, meaning it affects a very small number of patients.

Q: Can Lodepine affect mood or cause symptoms like depression or anxiety?

Official product information lists mood changes (including anxiety) and feelings of depression as potential side effects. These effects are generally classified as uncommon (affecting up to 1 in 100 people).

Q: Is it possible for Lodepine to become less effective over a long period of use?

Studies and regulatory endorsements support that this medication is suitable for a long-term treatment plan. The drug’s prolonged action supports its use in maintaining consistent blood pressure management over long periods.

Q: Can over-the-counter pain medications like ibuprofen be taken with Lodepine?

Regulatory drug interaction data warns that taking Amlodipine with NSAIDs (such as ibuprofen) may cause blood pressure to increase, potentially reducing the blood pressure-lowering effects of Lodepine. This combination may also affect kidney function in certain individuals.

Q: Are there known interactions between Lodepine and common herbal or dietary supplements?

Official safety data indicates that the herbal remedy St John's wort is thought to reduce the effectiveness of Amlodipine. Information on interactions with most other herbal supplements is generally not available, as they are not tested in the same way as prescription medicines.

Q: Does Lodepine interact with basic daily multivitamins?

Official drug interaction reports indicate that using Amlodipine together with some multivitamins that contain minerals may potentially decrease the effect of Amlodipine.

Q: Is Lodepine an appropriate treatment for people who also have diabetes?

Regulatory documents note that Amlodipine is used in the treatment of hypertension for patients who also have diabetes mellitus. Specific combination drug products containing Amlodipine may have contraindications related to other drugs used to manage diabetes.

Q: Is Lodepine available as a generic medicine?

Yes, regulatory data confirms that the active ingredient, Amlodipine Besylate, is widely available as an FDA-approved generic medication.

Q: Is there research evidence regarding Lodepine's effectiveness in different ethnic populations?

Clinical trials often include analysis of the drug's effectiveness in various racial and ethnic populations. Studies have evaluated Amlodipine-based regimens, for instance, in the African American patient population.

Q: How is Lodepine different from a beta-blocker?

Lodepine is in a class called calcium channel blockers which work mainly by relaxing blood vessels. Beta-blockers are a different class of medication that works to reduce the heart rate and force of heart muscle contraction.

Q: Does Lodepine have an effect on cholesterol levels?

Amlodipine alone is not a cholesterol-lowering medication. However, it is sometimes available in a fixed-dose combination product with the cholesterol-lowering drug atorvastatin.

How should Lodepine be stored and disposed of?

How to Store and Dispose of Lodepine (Amlodipine Besylate)?

Amlodipine Besylate tablets must be stored according to official regulatory guidelines to maintain stability and prevent unauthorized access.


Storage Requirements

The medication requires storage at controlled room temperature, specifically ranging from 20 C to 25 C (68 F to 77 F). Temperature excursions are permitted between 15 C and 30 C (59 F and 86 F). The tablets must be protected from excessive moisture and high heat. Keep the product in its original container and ensure the container is tightly closed when not in use.

Safety and Disposal

It is mandatory to keep Amlodipine Besylate out of the sight and reach of children. Unused or expired tablets must be disposed of safely, in accordance with local regulations for pharmaceutical waste. The product should not be disposed of via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lodepine found in:

A-Z Index: